SCHEMBL7835585

SCHEMBL7835585

COc1cccc2c1[C@@H]1CN(C(C)c3ccccc3)C[C@@H]1CO2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.43
LTA4H P09960 3/20 0.39
DRD2 P14416 3/20 0.38
DRD3 P35462 3/20 0.38
CYP2D6 P10635 2/20 0.38
NPC1 O15118 1/20 0.38
MTOR P42345 1/20 0.38
RAB9A P51151 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
MAPK1 P28482 1/20 0.38
THPO P40225 1/20 0.38
FTO Q9C0B1 1/20 0.38
MEN1 O00255 1/20 0.37
GMNN O75496 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7845967 1.00 HTR1A (0.43) HTR1ALTA4HDRD2DRD3CYP2D6
SCHEMBL8099072 1.00 HTR1A (0.43) HTR1ALTA4HDRD2DRD3CYP2D6
SCHEMBL8100761 1.00 HTR1A (0.43) HTR1ALTA4HDRD2DRD3CYP2D6
Hydrochloric Acid SCHEMBL7851181 0.99 HTR1A (0.42) HTR1ALTA4HDRD2DRD3CYP2D6
SCHEMBL8387323 0.85 CYP3A4 (0.36) HTR1ADRD2DRD3CYP2D6NPC1
SCHEMBL7844219 0.80 HTR1A (0.45) HTR1ACYP2D6MAPTCYP19A1CCR5
SCHEMBL8091669 0.80 HTR1A (0.45) HTR1ACYP2D6MAPTCYP19A1CCR5
SCHEMBL9458462 0.78 HTR1A (0.62) HTR1ADRD2
SCHEMBL9458475 0.78 HTR1A (0.62) HTR1ADRD2
SCHEMBL9458466 0.78 HTR1A (0.62) HTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0942911-B1 BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE ALPHA-1 ADRENERGIC COMPOUNDS ABBOTT LAB (US) 2001-10-17 EP disclosed
US-6046207-A FOR INHIBITING ALPHA-1 ADRENORECEPTORS AND TREATING BENIGN PROSTATIC HYPERPLASIA, ALSO CALLED BENIGN PROSTATIC HYPERTROPHY, OR OTHER UROLOGICAL OR GYNECOLOGICAL DISEASES SUCH AS BLADDER OUTLET OBSTRUCTION, NEUROGENIC BLADDER ABBOTT LABORATORIES 2000-04-04 US disclosed
US-5891882-A TREATING BENIGN PROSTATIC HYPERPLASIA OR OTHER UROLOGICAL DISEASES SUCH AS BLADDER OUTLET OBSTRUCTION AND NEUROGENIC BLADDER, OR GYNECOLOGICAL SYNDROMES SUCH AS DYSMENORRHEA ABBOTT LABORATORIES (US) 1999-04-06 US disclosed